David Babb

799 total citations
13 papers, 618 citations indexed

About

David Babb is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, David Babb has authored 13 papers receiving a total of 618 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cellular and Molecular Neuroscience, 4 papers in Molecular Biology and 4 papers in Physiology. Recurrent topics in David Babb's work include Neurotransmitter Receptor Influence on Behavior (7 papers), Smoking Behavior and Cessation (4 papers) and Nicotinic Acetylcholine Receptors Study (3 papers). David Babb is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (7 papers), Smoking Behavior and Cessation (4 papers) and Nicotinic Acetylcholine Receptors Study (3 papers). David Babb collaborates with scholars based in United States. David Babb's co-authors include Dorothy K. Hatsukami, Mehmet Sofuoglu, Marc Mooney, Scott Brown, Paul R. Pentel, Sheila Specker, Frances R. Levin, John Grabowski, David Nelson and Joni Jensen and has published in prestigious journals such as JAMA Psychiatry, Drug and Alcohol Dependence and Annals of Emergency Medicine.

In The Last Decade

David Babb

12 papers receiving 602 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Babb United States 11 252 159 121 120 90 13 618
Jeanne M. Manubay United States 21 275 1.1× 184 1.2× 118 1.0× 73 0.6× 164 1.8× 32 852
Elisse Kramer United States 16 187 0.7× 224 1.4× 53 0.4× 238 2.0× 204 2.3× 26 891
Marleen Wingen Netherlands 15 187 0.7× 84 0.5× 71 0.6× 92 0.8× 153 1.7× 22 775
Lisa H. Brauer United States 14 291 1.2× 242 1.5× 212 1.8× 97 0.8× 116 1.3× 19 714
Mark Daglish Australia 18 415 1.6× 111 0.7× 131 1.1× 67 0.6× 120 1.3× 40 920
MarkS. Gold United States 6 323 1.3× 104 0.7× 212 1.8× 71 0.6× 69 0.8× 7 604
Markus Banger Germany 16 134 0.5× 57 0.4× 72 0.6× 130 1.1× 89 1.0× 43 691
Wilfrid N. Raby United States 19 363 1.4× 49 0.3× 80 0.7× 149 1.2× 252 2.8× 29 898
Alexander Diehl Germany 15 255 1.0× 93 0.6× 126 1.0× 99 0.8× 85 0.9× 33 835
Thomas R. Kosten United States 15 482 1.9× 60 0.4× 202 1.7× 112 0.9× 194 2.2× 16 910

Countries citing papers authored by David Babb

Since Specialization
Citations

This map shows the geographic impact of David Babb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Babb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Babb more than expected).

Fields of papers citing papers by David Babb

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Babb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Babb. The network helps show where David Babb may publish in the future.

Co-authorship network of co-authors of David Babb

This figure shows the co-authorship network connecting the top 25 collaborators of David Babb. A scholar is included among the top collaborators of David Babb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Babb. David Babb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Pulia, Michael S., et al.. (2017). 387 Increasing Compliance With Repeat Lactate Measurement Utilizing Automated Repeat Lactate Ordering. Annals of Emergency Medicine. 70(4). S151–S151. 1 indexed citations
2.
Mooney, Marc, David V. Herin, Sheila Specker, et al.. (2015). Pilot study of the effects of lisdexamfetamine on cocaine use: A randomized, double-blind, placebo-controlled trial. Drug and Alcohol Dependence. 153. 94–103. 35 indexed citations
3.
Levin, Frances R., John J. Mariani, Sheila Specker, et al.. (2015). Extended-Release Mixed Amphetamine Salts vs Placebo for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cocaine Use Disorder. JAMA Psychiatry. 72(6). 593–593. 107 indexed citations
4.
Hatsukami, Dorothy K., Marc Mooney, Sharon E. Murphy, et al.. (2007). Effects of high dose transdermal nicotine replacement in cigarette smokers. Pharmacology Biochemistry and Behavior. 86(1). 132–139. 44 indexed citations
5.
Mooney, Marc, David Babb, Joni Jensen, & Dorothy K. Hatsukami. (2005). Interventions to increase use of nicotine gum: A randomized, controlled, single‐blind trial. Nicotine & Tobacco Research. 7(4). 565–579. 43 indexed citations
6.
Sofuoglu, Mehmet, David Babb, & Dorothy K. Hatsukami. (2003). Labetalol treatment enhances the attenuation of tobacco withdrawal symptoms by nicotine in abstinent smokers. Nicotine & Tobacco Research. 5(6). 947–953. 19 indexed citations
7.
Sofuoglu, Mehmet, David Babb, & Dorothy K. Hatsukami. (2002). Effects of progesterone treatment on smoked cocaine response in women. Pharmacology Biochemistry and Behavior. 72(1-2). 431–435. 99 indexed citations
8.
Sofuoglu, Mehmet, Scott Brown, David Babb, & Dorothy K. Hatsukami. (2001). Depressive symptoms modulate the subjective and physiological response to cocaine in humans. Drug and Alcohol Dependence. 63(2). 131–137. 34 indexed citations
9.
Sofuoglu, Mehmet, David Nelson, David Babb, & Dorothy K. Hatsukami. (2001). Intravenous cocaine increases plasma epinephrine and norepinephrine in humans. Pharmacology Biochemistry and Behavior. 68(3). 455–459. 47 indexed citations
10.
Sofuoglu, Mehmet, David Babb, & Dorothy K. Hatsukami. (2001). Progesterone treatment during the early follicular phase of the menstrual cycle: Effects on smoking behavior in women. Pharmacology Biochemistry and Behavior. 69(1-2). 299–304. 84 indexed citations
11.
Sofuoglu, Mehmet, Scott Brown, David Babb, Paul R. Pentel, & Dorothy K. Hatsukami. (2000). Effects of Labetalol Treatment on the Physiological and Subjective Response to Smoked Cocaine. Pharmacology Biochemistry and Behavior. 65(2). 255–259. 43 indexed citations
12.
Sofuoglu, Mehmet, et al.. (2000). Characteristics of research volunteers for inpatient cocaine studies. Addictive Behaviors. 25(5). 785–790. 10 indexed citations
13.
Sofuoglu, Mehmet, Scott Brown, David Babb, Paul R. Pentel, & Dorothy K. Hatsukami. (2000). Carvedilol affects the physiological and behavioral response to smoked cocaine in humans. Drug and Alcohol Dependence. 60(1). 69–76. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeanne M. Manubay Breakdown of academic impact, for papers by Elisse Kramer Breakdown of academic impact, for papers by Marleen Wingen Breakdown of academic impact, for papers by Lisa H. Brauer Breakdown of academic impact, for papers by Mark Daglish Breakdown of academic impact, for papers by MarkS. Gold Breakdown of academic impact, for papers by Markus Banger Breakdown of academic impact, for papers by Wilfrid N. Raby Breakdown of academic impact, for papers by Alexander Diehl Breakdown of academic impact, for papers by Thomas R. Kosten
Rankless by CCL
2026